Risk factors of short-term survival in the aged in elective colon cancer surgery: a population-based study.


Journal

International journal of colorectal disease
ISSN: 1432-1262
Titre abrégé: Int J Colorectal Dis
Pays: Germany
ID NLM: 8607899

Informations de publication

Date de publication:
Feb 2020
Historique:
accepted: 04 12 2019
pubmed: 19 12 2019
medline: 18 11 2020
entrez: 19 12 2019
Statut: ppublish

Résumé

Patients aged > 80 years represent an increasing proportion of colon cancer diagnoses. Selecting patients for elective surgery is challenging because of possibly compromised health status and functional decline. The aim of this retrospective, population-based study was to identify risk factors and health measures that predict short-term mortality after elective colon cancer surgery in the aged. All patients > 80 years operated electively for stages I-III colon cancer from 2005 to 2016 in four Finnish hospitals were included. The prospectively collected data included comorbidities, functional status, postoperative surgical and medical outcomes as well as mortality data. A total of 386 patients (mean 84.0 years, range 80-96, 56% female) were included. Male gender (46% vs 35%, p = 0.03), higher BMI (51% vs 37%, p = 0.02), diabetes mellitus (51% vs 37%, p = 0.02), coronary artery disease (52% vs 36%, p = 0.003) and rheumatic diseases (67% vs 39%, p = 0.03) were related to higher risk of complications. The severe complications were more common in patients with increased preoperative hospitalizations (31% vs 15%, p = 0.05) and who lived in nursing homes (30% vs 17%, p = 0.05). The 30-day and 1-year mortality rates were 6.0% and 15% for all the patients compared with 30% and 45% in patients with severe postoperative complications (p < 0.001). Severe postoperative complications were the only significant patient-related variable affecting 1-year mortality (OR 9.60, 95% CI 2.33-39.55, p = 0.002). The ability to identify preoperatively patients at high risk of decreased survival and thus prevent severe postoperative complications could improve overall outcome of aged colon cancer patients.

Identifiants

pubmed: 31848741
doi: 10.1007/s00384-019-03488-8
pii: 10.1007/s00384-019-03488-8
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

307-315

Subventions

Organisme : Tays
ID : Competitive Research Financing of the Expert

Références

Am J Surg. 2019 Apr;217(4):677-681
pubmed: 30473227
BMC Cancer. 2019 Jan 22;19(1):98
pubmed: 30670009
Scand J Surg. 2019 Jun;108(2):144-151
pubmed: 30187819
Eur J Surg Oncol. 2019 Aug;45(8):1396-1402
pubmed: 31003722
J Acad Nutr Diet. 2019 Mar;119(3):375-393
pubmed: 29685825
Ann R Coll Surg Engl. 2019 Feb;101(2):126-132
pubmed: 30354186
Med J Aust. 2010 Sep 6;193(S5):S62-7
pubmed: 21542449
Gut. 2017 Apr;66(4):683-691
pubmed: 26818619
Eur J Cancer. 2015 Oct;51(15):2158-2168
pubmed: 26421819
Clin Nutr. 2005 Jun;24(3):466-77
pubmed: 15896435
J Cancer Res Clin Oncol. 2017 Sep;143(9):1879-1889
pubmed: 28534171
Dis Colon Rectum. 2010 May;53(5):735-43
pubmed: 20389207
Acta Oncol. 2018 Nov;57(11):1458-1466
pubmed: 30280625
Ann Oncol. 2012 Oct;23(10):2479-516
pubmed: 23012255
Ann Surg Oncol. 2018 Dec;25(13):3874-3882
pubmed: 30244418
Eur J Cancer. 2019 Jul;116:1-9
pubmed: 31163335
PLoS One. 2016 Feb 05;11(2):e0148076
pubmed: 26848761
Eur J Surg Oncol. 2018 Nov;44(11):1685-1702
pubmed: 30150158
Gerontol Geriatr Med. 2017 May 02;3:2333721417706299
pubmed: 28516129
Colorectal Dis. 2018 Jan;20(1):16-25
pubmed: 28649755
J Gastrointest Surg. 2015 Apr;19(4):756-65
pubmed: 25617077
Ann Surg. 2011 May;253(5):947-52
pubmed: 21490452
Colorectal Dis. 2014 Jun;16(6):433-41
pubmed: 24460639
Gut. 2011 Jun;60(6):806-13
pubmed: 21486939
Gastrointest Tumors. 2017 Sep;4(1-2):36-44
pubmed: 29071263
Eur J Cancer. 2014 May;50(7):1276-83
pubmed: 24447833
Ann Surg Oncol. 2011 Jun;18(6):1533-9
pubmed: 21445672
Colorectal Dis. 2009 May;11(4):354-64; discussion 364-5
pubmed: 19016817
Int J Colorectal Dis. 2013 Jul;28(7):941-7
pubmed: 23242272
Eur J Surg Oncol. 2019 Sep;45(9):1575-1583
pubmed: 31053476
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Ann Surg Oncol. 2016 Dec;23(13):4293-4301
pubmed: 27459985
Ann Surg Oncol. 2013 May;20(5):1427-35
pubmed: 23292483
Ann R Coll Surg Engl. 2016 Mar;98(3):216-21
pubmed: 26890839
Br J Cancer. 2017 Jan;116(3):389-397
pubmed: 28056465
Ann Oncol. 2015 Mar;26(3):463-76
pubmed: 25015334
Ann Surg Oncol. 2012 Aug;19(8):2428-34
pubmed: 22396000

Auteurs

Susanna Niemeläinen (S)

Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland. susanna.niemelainen@pshp.fi.
Department of Surgery, Tays Hatanpää, P.O. Box 2000, 33521, Tampere, Finland. susanna.niemelainen@pshp.fi.

Heini Huhtala (H)

Faculty of Social Sciences, Tampere University, Tampere, Finland.

Anu Ehrlich (A)

Central Hospital of Central Finland, Jyväskylä, Finland.

Jyrki Kössi (J)

Päijät-Häme Central Hospital, Lahti, Finland.

Esa Jämsen (E)

Centre of Geriatrics, Tampere University Hospital, Tampere, Finland.
Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Gerontology Research Center (GEREC), Tampere, Finland.

Marja Hyöty (M)

Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH